Annual CFF
-$140.18 M
-$576.90 M-132.10%
December 31, 2023
Summary
- As of February 7, 2025, COLL annual cash flow from financing activities is -$140.18 million, with the most recent change of -$576.90 million (-132.10%) on December 31, 2023.
- During the last 3 years, COLL annual CFF has fallen by -$426.65 million (-148.93%).
- COLL annual CFF is now -132.10% below its all-time high of $436.72 million, reached on December 31, 2022.
Performance
COLL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$149.03 M
+$263.24 M+230.49%
September 30, 2024
Summary
- As of February 7, 2025, COLL quarterly cash flow from financing activities is $149.03 million, with the most recent change of +$263.24 million (+230.49%) on September 30, 2024.
- Over the past year, COLL quarterly CFF has increased by +$244.44 million (+256.19%).
- COLL quarterly CFF is now -71.22% below its all-time high of $517.76 million, reached on March 31, 2022.
Performance
COLL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$87.15 M
+$244.44 M+73.72%
September 30, 2024
Summary
- As of February 7, 2025, COLL TTM cash flow from financing activities is -$87.15 million, with the most recent change of +$244.44 million (+73.72%) on September 30, 2024.
- Over the past year, COLL TTM CFF has increased by +$11.02 million (+11.23%).
- COLL TTM CFF is now -119.81% below its all-time high of $439.93 million, reached on March 31, 2022.
Performance
COLL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
COLL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -132.1% | +256.2% | +11.2% |
| 3 y3 years | -148.9% | +256.2% | +11.2% |
| 5 y5 years | -19.6% | +256.2% | +11.2% |
COLL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -132.1% | at low | -71.2% | +230.5% | -119.8% | +73.7% |
| 5 y | 5-year | -132.1% | at low | -71.2% | +230.5% | -119.8% | +73.7% |
| alltime | all time | -132.1% | at low | -71.2% | +230.5% | -119.8% | +73.7% |
Collegium Pharmaceutical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $149.03 M(-230.5%) | -$87.15 M(-73.7%) |
| Jun 2024 | - | -$114.21 M(+110.9%) | -$331.59 M(+26.3%) |
| Mar 2024 | - | -$54.15 M(-20.2%) | -$262.62 M(+87.3%) |
| Dec 2023 | -$140.18 M(-132.1%) | -$67.83 M(-28.9%) | -$140.18 M(+42.8%) |
| Sep 2023 | - | -$95.41 M(+110.9%) | -$98.17 M(+188.6%) |
| Jun 2023 | - | -$45.24 M(-166.2%) | -$34.01 M(+166.9%) |
| Mar 2023 | - | $68.30 M(-364.5%) | -$12.74 M(-102.9%) |
| Dec 2022 | $436.72 M(-589.0%) | -$25.82 M(-17.4%) | $436.72 M(+4.0%) |
| Sep 2022 | - | -$31.25 M(+30.4%) | $420.05 M(-1.1%) |
| Jun 2022 | - | -$23.97 M(-104.6%) | $424.79 M(-3.4%) |
| Mar 2022 | - | $517.76 M(-1318.3%) | $439.93 M(-592.6%) |
| Dec 2021 | -$89.30 M(-131.2%) | -$42.50 M(+60.3%) | -$89.30 M(+50.8%) |
| Sep 2021 | - | -$26.51 M(+200.2%) | -$59.21 M(+32.4%) |
| Jun 2021 | - | -$8.83 M(-23.0%) | -$44.73 M(-7.0%) |
| Mar 2021 | - | -$11.47 M(-7.5%) | -$48.11 M(-116.8%) |
| Dec 2020 | $286.47 M(>+9900.0%) | -$12.40 M(+3.1%) | $286.47 M(-4.6%) |
| Sep 2020 | - | -$12.03 M(-1.5%) | $300.29 M(-4.0%) |
| Jun 2020 | - | -$12.21 M(-103.8%) | $312.73 M(-3.8%) |
| Mar 2020 | - | $323.12 M(>+9900.0%) | $324.99 M(>+9900.0%) |
| Dec 2019 | $2.04 M | $1.41 M(+247.4%) | $2.04 M(-106.2%) |
| Sep 2019 | - | $407.00 K(+698.0%) | -$33.05 M(-50.3%) |
| Jun 2019 | - | $51.00 K(-69.8%) | -$66.53 M(-43.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $169.00 K(-100.5%) | -$116.64 M(-0.5%) |
| Dec 2018 | -$117.20 M(-450.1%) | -$33.67 M(+1.8%) | -$117.20 M(+98.7%) |
| Sep 2018 | - | -$33.07 M(-33.9%) | -$58.97 M(+255.5%) |
| Jun 2018 | - | -$50.06 M(>+9900.0%) | -$16.59 M(-150.2%) |
| Mar 2018 | - | -$388.00 K(-101.6%) | $33.04 M(-1.3%) |
| Dec 2017 | $33.48 M(-75.3%) | $24.55 M(+163.8%) | $33.48 M(-64.7%) |
| Sep 2017 | - | $9.31 M(-2249.9%) | $94.75 M(+11.1%) |
| Jun 2017 | - | -$433.00 K(-966.0%) | $85.25 M(+0.2%) |
| Mar 2017 | - | $50.00 K(-99.9%) | $85.06 M(-37.3%) |
| Dec 2016 | $135.56 M(+16.9%) | $85.83 M(<-9900.0%) | $135.56 M(+176.1%) |
| Sep 2016 | - | -$194.00 K(-68.8%) | $49.10 M(+0.1%) |
| Jun 2016 | - | -$622.00 K(-101.2%) | $49.02 M(-59.7%) |
| Mar 2016 | - | $50.55 M(-8035.5%) | $121.50 M(+4.8%) |
| Dec 2015 | $115.99 M(+863.5%) | -$637.00 K(+140.4%) | $115.99 M(-4.7%) |
| Sep 2015 | - | -$265.00 K(-100.4%) | $121.66 M(-4.9%) |
| Jun 2015 | - | $71.86 M(+59.6%) | $127.92 M(+128.2%) |
| Mar 2015 | - | $45.04 M(+795.2%) | $56.04 M(+365.6%) |
| Dec 2014 | $12.04 M(-2.5%) | $5.03 M(-16.1%) | $12.04 M(+71.8%) |
| Sep 2014 | - | $5.99 M(<-9900.0%) | $7.01 M(+591.0%) |
| Jun 2014 | - | -$17.00 K(-101.6%) | $1.01 M(-1.6%) |
| Mar 2014 | - | $1.03 M | $1.03 M |
| Dec 2013 | $12.35 M | - | - |
FAQ
- What is Collegium Pharmaceutical annual cash flow from financing activities?
- What is the all time high annual CFF for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical annual CFF year-on-year change?
- What is Collegium Pharmaceutical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical quarterly CFF year-on-year change?
- What is Collegium Pharmaceutical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical TTM CFF year-on-year change?
What is Collegium Pharmaceutical annual cash flow from financing activities?
The current annual CFF of COLL is -$140.18 M
What is the all time high annual CFF for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high annual cash flow from financing activities is $436.72 M
What is Collegium Pharmaceutical annual CFF year-on-year change?
Over the past year, COLL annual cash flow from financing activities has changed by -$576.90 M (-132.10%)
What is Collegium Pharmaceutical quarterly cash flow from financing activities?
The current quarterly CFF of COLL is $149.03 M
What is the all time high quarterly CFF for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high quarterly cash flow from financing activities is $517.76 M
What is Collegium Pharmaceutical quarterly CFF year-on-year change?
Over the past year, COLL quarterly cash flow from financing activities has changed by +$244.44 M (+256.19%)
What is Collegium Pharmaceutical TTM cash flow from financing activities?
The current TTM CFF of COLL is -$87.15 M
What is the all time high TTM CFF for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high TTM cash flow from financing activities is $439.93 M
What is Collegium Pharmaceutical TTM CFF year-on-year change?
Over the past year, COLL TTM cash flow from financing activities has changed by +$11.02 M (+11.23%)